Arthritis Innovation Overview
- Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$324K
Arthritis Innovation General Information
Description
Developer of drug-delivery copolymers designed to meet clinical needs in orthopedics and arthritis. The company's copolymers are formed using an injectable and biodegradable technology that is compatible with small molecules, peptides, proteins, and antibodies, which later form a semi-solid depot when exposed to an aqueous environment and can facilitate delivery of both hydrophobic and hydrophilic active pharmaceutical ingredients, enabling medical researchers and surgeons to facilitate the management of pain and inflammation following total knee replacement.
Contact Information
Primary Industry
Drug Delivery
Other Industries
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Primary Office
- 5 Fallingbrook Crescent
- Toronto, Ontario M1N 1B1
- Canada
+1 (416) 000-0000
Arthritis Innovation Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 09-Feb-2017 | $324K | 00000 | Completed | Startup |
Arthritis Innovation Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wayne Marshall Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
| Glenys Foster-Roberts | Vice President Quality and development & Board Member |
Arthritis Innovation Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Levitt | Arthritis Innovation | Board Member | 000 0000 |
| Glenys Foster-Roberts | Arthritis Innovation | Vice President Quality and development & Board Member | 000 0000 |
| Mark Krembil | Arthritis Innovation | Board Member | 000 0000 |
| Nizar Mahomed | Self | Board Member | 000 0000 |
| Wayne Marshall Ph.D | Arthritis Innovation | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |